Standout Papers

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled,... 2011 2026 2016 2021 528
  1. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial (2011)
    Ludwig Kappos, David Li et al. The Lancet

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep
2025 Standout
Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
2 intermediate papers

Works of Ming Yin being referenced

Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background
2013
Identification of Hub Genes Related to the Recovery Phase of Irradiation Injury by Microarray and Integrated Gene Network Analysis
2011

Author Peers

Author Last Decade Papers Cites
Ming Yin 681 215 309 566 459 73 2.2k
Roman Fischer 641 230 461 308 615 46 2.3k
Carmelo Muià 759 212 337 563 518 64 2.5k
Sofia Mariotto 956 154 409 218 432 55 2.8k
Xiaojuan Liu 1278 272 294 229 422 114 2.6k
Leonard M. Hillegass 673 119 278 231 489 42 2.1k
Yi Chu 894 125 743 183 334 79 2.9k
Yajun Wu 1017 127 495 182 159 54 2.4k
Akbar Ahmad 669 88 289 198 266 48 1.9k
Kyoung‐jin Min 1598 188 229 278 523 108 3.1k
Shiying Huang 733 301 334 187 153 99 2.2k

All Works

Loading papers...

Rankless by CCL
2026